DEANNA MINOR: Open Payments
NPI 1376912386 · WOODLAWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,008 in 111 payments from 12 companies in 2025. Trend: 2023 $1,682 · 2024 $1,839 · 2025 $2,008
Food & beverage: $2,008
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 28 | $424 |
| Otsuka America Pharmaceutical, Inc. | 12 | $237 |
| ABBVIE INC. | 12 | $228 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $206 |
| Teva Pharmaceuticals USA, Inc. | 8 | $182 |
| E.R. Squibb & Sons, L.L.C. | 11 | $171 |
| Janssen Pharmaceuticals, Inc | 8 | $169 |
| Braeburn Inc. | 8 | $152 |
| Alkermes, Inc. | 6 | $109 |
| Lundbeck LLC | 4 | $84 |
Products named: INGREZZA, VRAYLAR, REXULTI, CAPLYTA, COBENFY, INVEGA SUSTENNA, BRIXADI, AUSTEDO XR.
Industry payments across TN — which companies pay providers there.
